pharma
Expand Current Footprint in Europe to Tap into High-end London MarketCreate New Synergy to Support the Long-term Growth of the Group HONG KONG, Jan 28, 2022 - (ACN Newswire) - EuroEyes International Eye Clinic Limited ("EuroEyes" or the "Company", together with its subsidiaries, the "Group", stock code: 1846), a leading global vision correction service provider, is pleased to announce that EuroEyes UK, a wholly-owned subsidiary of the Company, has entered into a Share Purchase Agreement ("Share Purchase Agreement") to acquire the entire issued shares in London Vision Clinic Partners Limited ("...
ACN Newswire
ADELAIDE, AUS, Jan 5, 2022 - (ACN Newswire) - TrialWire(TM) is pleased to announce new Autism (ASD) clinical studies are now available on the TrialWire Platform. More than 6 million people have used TrialWire over the past few years to find clinical trials that are right for them at clinics and specialist centers near them. The ASD studies on TrialWire are available in Australia, New Zealand, and the U.S. They include studies for children, teenagers and adults around ASD possible causes, and managing symptoms that can impact people's lives. You can search for a study near you and find your loc...
ACN Newswire
HONG KONG, Dec 30, 2021 - (ACN Newswire) - Sirnaomics Ltd. ("Sirnaomics" or "Company", together with its subsidiaries, the "Group", stock code: 2257.HK), the RNA therapeutics biopharmaceutical company with strong presence in both China and the U.S., and the first company to achieve positive Phase IIa clinical outcomes in oncology for an RNAi therapeutics, is officially listed and commenced trading on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") today. The total number of offer shares under the Global Offering amounts to 7,540,000 shares, with the final offer price determi...
ACN Newswire
HONG KONG, Dec 17, 2021 - (ACN Newswire) - 2021 the 11th Hong Kong International Finance Forum & China Securities Golden Bauhinia Awards Ceremony, themed "The 14th Five-Year, a New Journey", was held at Hong Kong Convention and Exhibition Center dated December 17, 2021. Around 200 financial officials and senior officers in securities firms, venture capital institutions, and listed companies from Mainland China and Hong Kong, as well as abroad, attended the event. Carrie Lam, Chief Executive of the Hong Kong Special Administrative Region, Jiang Zaizhong, member of the national committee of CPPC...
ACN Newswire
Foster City, CA, Shanghai and Hangzhou, China, Nov 22, 2021 - (ACN Newswire) - Apollomics Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced that the first patient has been successfully dosed in a Phase 3 clinical trial of APL-106 (uproleselan injection) for the treatment of adults with relapsed or refractory acute myeloid leukemia (AML) in China. Apollomics licensed the Greater China rights for uproleselan from GlycoMimetics. "As our first Phase 3 clinical trial, dosing of the first patient wit...
ACN Newswire
Asia-based next-generation oncology diagnostic powerhouse to take on global market with total solutions to patients, medical professionals, pharmaceutical companies, and research institutes HONG KONG, Nov 22, 2021 - (ACN Newswire) - ACT Genomics Holdings Co. Ltd. ("ACT Genomics" or "the Group") a leading cancer solution provider in Asia, announced today that it has merged with Sanomics Holdings Limited ("Sanomics"), a champion in lung cancer diagnostics in Hong Kong and Thailand. Both ACT Genomics and Sanomics are park companies of Hong Kong Science and Technology Parks Corporation (HKSTP) and...
ACN Newswire
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら